Latest News Archive
Please select Category, Year, and then Month to display items
10 July 2018
Photo Supplied
Shindré-Lee Simmons, one of the veterans in the Kovsie women’s hockey team for this year’s national student championship.
The Kovsie men’s and women’s hockey teams have positive expectations for the University Sport South Africa (USSA) national student tournament.
The USSA championships were hosted by the University of the Free State (UFS) from 2 to 6 July 2018. This year’s championships will have 45 competing teams and will thus be the biggest ever USSA hockey tournament.
For the female squad to qualify for the 2019 Varsity Sports tournament, they have to secure a spot among the top-seven teams. In order to get back into the A section, the Kovsie men’s team must win their tournament.
The matches are scheduled to take place on the UFS Bloemfontein Campus astro fields.
The UFS women’s team, captained by Antonet Louw, is set to play on Monday at 15:35 against Nelson Mandela University (NMU); on Tuesday at 17:00 against the University of Johannesburg (UJ); and on Wednesday at 18:25 against North-West University (NWU). The play-off matches will take place on Wednesday, Thursday, and Friday.
The men’s team, with Cheslyn Neethling as captain, will play on Monday at 17:00 against the Central University of Technology; on Tuesday at 15:35 against the Tswane University of Technology; on Wednesday at 17:00 against the Vaal University of Technology; on Thursday at 18:25 against the University of KwaZulu-Natal; and on Friday at 15:35 against Rhodes University.
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”